Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical validation of dried blood spot monitoring for vancomycin and creatinine
NL-OMON54384Completed
- Sponsor
- Erasmus MC
- Start
- Mar 2022
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of vancomycin in bacterial disease, sponsored by Erasmus MC. Primary endpoint: Clinical validation of DBS vancomycin and creatinine measurement. Started Mar 2022; status: completed.
02
Drugs
vancomycin
03
Conditions
bacterial disease
Beyond the preview
Go deeper on NL-OMON54384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54384.